Table 4.
Concomitant medications.
| Medication family | Intake | Change at six months follow-up | ||||
|---|---|---|---|---|---|---|
| Total | Stopped taking this medication | Dosage decreased | Has not changed | Dosage increased | New medication | |
| Antipsychotics, n (%) | 55 | 11 (20) | 3 (5) | 41 (75) | 0 | 0 |
| Antiepileptics, n (%) | 46 | 6 (13) | 0 | 35 (76) | 2 (4.5) | 3 (6.5) |
| Antidepressants, n (%) | 10 | 3 (30) | 0 | 4 (40) | 1 (10) | 2 (20) |
| Hypnotics and sedatives, n (%) | 10 | 2 (20) | 1 (10) | 7 (70) | 0 | 0 |
| Anxiolytics, n (%) | 7 | 2 (28) | 0 | 5 (72) | 0 | 0 |
Concomitant medications use at the baseline and six months follow up in patients responding to the six-month questionnaire.